Request Trial

Marisa Woutersen

Key details

Marisa Woutersen is a senior reporter for Life Sciences Intellectual Property Review and World IP Review. She largely covers intellectual property developments across the global life sciences sector, including pharmaceuticals, biotechnology, medtech, AI, M&A and regulation.

Since joining Newton Media in 2023, Marisa has reported across a wide range of topics, from the rise of generative AI and its impact on the creative industries to the crossover between intellectual property and sport, including issues affecting athletes, as well as global pharmaceutical disputes, vaccine technology, access to medicines and life sciences M&A.

She has reported live from court and regularly travels to international conferences, where she interviews lawyers, business leaders and other key industry figures.

Marisa holds a Master’s in International Law and a BA in Politics and International Relations from the University of Sussex, and is currently completing her NCTJ Diploma in Journalism.

Reset all filters
Article Type
Channels & Sectors
Geography
Company
Refine search
Total results: 22

Articles by Marisa Woutersen

What's AI best at? In-house teams are still learning
In-house counsel
What's AI best at? In-house teams are still learning
AI is helping legal and IP teams handle more work without adding headcount, but in-house counsel at LSPN Europe warn that knowing when not to rely on the technology is just as important as knowing how to use it.   2 October 2026
WATCH: Genevant IP director on tackling UPC-EPO opposition divide
In-house counsel
WATCH: Genevant IP director on tackling UPC-EPO opposition divide
With patent validity increasingly being fought over in both the UPC and EPO, Genevant Sciences’ Stephan Kutik talks to LSIPR about keeping parallel proceedings aligned and why teamwork matters.   1 October 2026
5 LSPN takeaways: What’s keeping Europe’s IP teams on their toes?
Regulation & Industry
5 LSPN takeaways: What’s keeping Europe’s IP teams on their toes?
LSPN Europe made its Basel debut, and two days of conversations showed just how much is changing for life sciences professionals—both in how they work and what they are being asked to do. Marisa Woutersen tallies up the talking points.   1 October 2026
Pharma
Lilly loses Fed Circ rehearing bid, sparking enablement questions
The decision leaves a $177 million verdict against Lilly intact, but a dissenting judge has warned the ruling could “undermine medical innovation” by allowing overly broad patent claims to survive and provide a way around the Supreme Court’s Amgen decision.   1 October 2026
Biotech
Scientist and Chinese biotech targeted by Beam in secrets suit
The gene-editing company has accused a former employee of secretly co-founding a Chinese biotech while still at the company, in a trade secrets lawsuit involving rival base-editing therapies and disputed patent filings.   29 September 2026
Pharma
Takeda sees off UK challenge to Elvanse SPC
Can a drug’s ‘inactive’ precursor qualify for a multi-million pound patent extension? The UK High Court has just delivered a ruling on Takeda's ADHD drug Elvanse, weighing regulatory precedent against a conflicting German decision.   28 September 2026
Pharma
Mylan throws down new gauntlet in Novo Wegovy patent fight
Another Wegovy patent has been drawn into the long-running dispute between Mylan and Novo Nordisk over proposed generic versions of the weight-loss drug.   25 September 2026
Pharma
Novartis defeats Orange Book challenge but suffers EU setback
An Entresto Orange Book listing has survived a challenge in the US, while two trademark disputes handed Novartis contrasting fortunes at a European court.   24 September 2026
Pharma
Behind the case: How Novartis defended its blockbuster Entresto in the UK
After a run of UK decisions going against major pharma patents on plausibility, Novartis bucked the trend with Entresto. The company’s lead counsel from Bristows explains why and what patentees can take from the ruling.   22 September 2026
Careers
Benesch adds former McDermott IP practice head
The hire brings more than three decades of experience across patent litigation, prosecution, licensing and cross-border matters, advising clients in the medical devices, automotive, manufacturing, consumer products, software and electronics sectors.   21 September 2026

Not finding what you're looking for, please try resetting your applied search and filters,
or try the full site search.